Evidence map›Paper›PMID 35650028›Full record

ArticleMagnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine2023

Utility of Wavelet Denoising with Geometry Factor Weighting for Gadoxetic Acid-enhanced Hepatobiliary-phase MR Imaging.

Shota Kondo, Yuko Nakamura, Toru Higaki, Takashi Nishihara, Masahiro Takizawa, Toru Shirai, Motoshi Fujimori, Yoshitaka Bito, Keigo Narita, Takahiro Sueoka and 3 more

Open access · diamondAbstract read
In one paragraph

Article in Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Shota KondoDepartment of Diagnostic Radiology, Hiroshima University.
Yuko NakamuraDepartment of Diagnostic Radiology, Hiroshima University.
Toru HigakiDepartment of Diagnostic Radiology, Hiroshima University.
Takashi NishiharaFUJIFILM Healthcare Corporation.
Masahiro TakizawaFUJIFILM Healthcare Corporation.
Toru ShiraiFUJIFILM Healthcare Corporation.
Motoshi FujimoriFUJIFILM Healthcare Corporation.
Yoshitaka BitoFUJIFILM Healthcare Corporation.
Keigo NaritaDepartment of Diagnostic Radiology, Hiroshima University.
Takahiro SueokaDepartment of Diagnostic Radiology, Hiroshima University.
Yukiko HondaDepartment of Diagnostic Radiology, Hiroshima University.
Chihiro TaniDepartment of Diagnostic Radiology, Hiroshima University.
Kazuo AwaiDepartment of Diagnostic Radiology, Hiroshima University.
Hiroshima University · JPFujifilm (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe wavelet denoising with geometry factor weighting (g-denoising) method can reduce the image noise by adapting to spatially varying noise levels induced by parallel imaging. The aim of this study was to investigate the clinical applicability of g-denoising on hepatobiliary-phase (HBP) images with gadoxetic acid.

methodsWe subjected 53 patients suspected of harboring hepatic neoplastic lesions to gadoxetic acid-enhanced HBP imaging with and without g-denoising (g

resultsThe liver-to-portal- and liver-to-muscle CNR and the SNR were significantly higher on g

conclusionAt gadoxetic acid-enhanced HBP imaging, g-denoising yielded a better image quality than conventional HBP imaging although the anatomic details may be degraded.

Indexed as

Contrast MediaLiver NeoplasmsGadolinium DTPAHumansLiverMagnetic Resonance ImagingRetrospective StudiesContrast MediaGadolinium DTPAgadolinium ethoxybenzyl DTPAdenoisinggeometry factor weightinghepatobiliary phaseparallel-imaging

Identifiers

PMID35650028
PMCPMC10086400
OpenAlexW4282926652

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.